94 related articles for article (PubMed ID: 8970510)
1. Improvement of radiation treatment planning in squamous-cell head and neck cancer by immuno-SPECT.
Adamietz IA; Baum RP; Schemman F; Niesen A; Knecht R; Saran F; Tieku S; Boniface GR; Hör G; Böttcher HD
J Nucl Med; 1996 Dec; 37(12):1942-6. PubMed ID: 8970510
[TBL] [Abstract][Full Text] [Related]
2. [Value of SPECT-immunoscintigraphy in radiation treatment planning for patients with squamous cell carcinomas in the head and neck area].
Adamietz IA; Schemmann F; Baum RP; Knecht R; Saran F; Mose S; Thilmann C; Hör G; Böttcher HD
Strahlenther Onkol; 1995 May; 171(5):278-83. PubMed ID: 7770783
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer.
de Bree R; Roos JC; Quak JJ; den Hollander W; Snow GB; van Dongen GA
Clin Cancer Res; 1995 Jun; 1(6):591-8. PubMed ID: 9816020
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunoscintigraphy of head and neck cancer using 99mTc-labeled monoclonal antibody E48 F(ab')2.
van Dongen GA; Leverstein H; Roos JC; Quak JJ; van den Brekel MW; van Lingen A; Martens HJ; Castelijns JA; Visser GW; Meijer CJ
Cancer Res; 1992 May; 52(9):2569-74. PubMed ID: 1568225
[TBL] [Abstract][Full Text] [Related]
5. A novel technetium-99m labeled monoclonal antibody (174H.64) for staging head and neck cancer by immuno-SPECT.
Baum RP; Adams S; Kiefer J; Niesen A; Knecht R; Howaldt HP; Hertel A; Adamietz IA; Sykes T; Boniface GR
Acta Oncol; 1993; 32(7-8):747-51. PubMed ID: 8305222
[TBL] [Abstract][Full Text] [Related]
6. Clinical imaging of head and neck cancer with technetium-99m-labeled monoclonal antibody E48 IgG or F(ab')2.
de Bree R; Roos JC; Quak JJ; den Hollander W; van den Brekel MW; van der Wal JE; Tobi H; Snow GB; van Dongen GA
J Nucl Med; 1994 May; 35(5):775-83. PubMed ID: 8176458
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunoscintigraphy of squamous cell carcinoma in the head and neck region.
Heissler E; Grünert B; Barzen G; Fritsche L; Hell B; Felix R; Bier J
Int J Oral Maxillofac Surg; 1994 Jun; 23(3):149-52. PubMed ID: 7930767
[TBL] [Abstract][Full Text] [Related]
8. Thallium-201 SPECT in the diagnosis of head and neck cancer.
Valdés Olmos RA; Balm AJ; Hilgers FJ; Koops W; Loftus BM; Tan IB; Muller SH; Hoefnagel CA; Gregor RT
J Nucl Med; 1997 Jun; 38(6):873-9. PubMed ID: 9189132
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunodiagnosis of lymph node metastases in head and neck cancer.
de Bree R; Roos JC; Verel I; van Dongen GA; Snow GB
Oral Dis; 2003 Sep; 9(5):241-8. PubMed ID: 14628891
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m-MIBI in primary and recurrent head and neck tumors: contribution of bone SPECT image fusion.
Leitha T; Glaser C; Pruckmayer M; Rasse M; Millesi W; Lang S; Nasel C; Backfrieder W; Kainberger F
J Nucl Med; 1998 Jul; 39(7):1166-71. PubMed ID: 9669388
[TBL] [Abstract][Full Text] [Related]
11. [Immunoscintigraphy of carcinomas in the area of the head-neck with technetium-99m marked monoclonal antibody 174H.64. A new diagnostic procedure].
Kiefer J; Baum RP; Knecht R; Hertel A; Niesen A; von Ilberg C; Hör G
HNO; 1994 Sep; 42(9):546-52. PubMed ID: 7989226
[TBL] [Abstract][Full Text] [Related]
12. Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-D-glucose SPECT.
Mukherji SK; Drane WE; Mancuso AA; Parsons JT; Mendenhall WM; Stringer S
Radiology; 1996 Jun; 199(3):761-6. PubMed ID: 8638002
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancer.
de Bree R; Roos JC; Quak JJ; den Hollander W; Wilhelm AJ; van Lingen A; Snow GB; Dongen GA
Clin Cancer Res; 1995 Mar; 1(3):277-86. PubMed ID: 9815983
[TBL] [Abstract][Full Text] [Related]
14. Safety and biodistribution of 99mTechnetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patients.
Stroomer JW; Roos JC; Sproll M; Quak JJ; Heider KH; Wilhelm BJ; Castelijns JA; Meyer R; Kwakkelstein MO; Snow GB; Adolf GR; van Dongen GA
Clin Cancer Res; 2000 Aug; 6(8):3046-55. PubMed ID: 10955783
[TBL] [Abstract][Full Text] [Related]
15. SPECT-CT for topographic mapping of sentinel lymph nodes prior to gamma probe-guided biopsy in head and neck squamous cell carcinoma.
Wagner A; Schicho K; Glaser C; Zettinig G; Yerit K; Lang S; Klug C; Leitha T
J Craniomaxillofac Surg; 2004 Dec; 32(6):343-9. PubMed ID: 15555515
[TBL] [Abstract][Full Text] [Related]
16. Head and neck cancer localization with indium labelled carcinoembryonic antigen: a pilot project.
Timon CI; McShane D; Hamilton D; Walsh MA
J Otolaryngol; 1991 Aug; 20(4):283-7. PubMed ID: 1920585
[TBL] [Abstract][Full Text] [Related]
17. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.
Miller FR; Karnad AB; Eng T; Hussey DH; Stan McGuff H; Otto RA
Head Neck; 2008 Jan; 30(1):28-34. PubMed ID: 17657782
[TBL] [Abstract][Full Text] [Related]
18. [Scintigraphic imaging of head and neck cancers with 99m technetium (v) dimercaptosuccinic acid. A prospective clinical study].
Heinritz H; Marienhagen J; Wolf F; Schuster B; Stenglein C; Iro H
HNO; 1992 Nov; 40(11):437-41. PubMed ID: 1335446
[TBL] [Abstract][Full Text] [Related]
19. Preoperative scintigraphy and operative probe scintimetry of colorectal carcinoma using technetium-99m-88BV59.
Moffat FL; Vargas-Cuba RD; Serafini AN; Jabir AM; Sfakianakis GN; Sittler SY; Robinson DS; Crichton VZ; Subramanian R; Murray JH
J Nucl Med; 1995 May; 36(5):738-45. PubMed ID: 7738642
[TBL] [Abstract][Full Text] [Related]
20. The impact of routine CT of the chest on the diagnosis and management of newly diagnosed squamous cell carcinoma of the head and neck.
Reiner B; Siegel E; Sawyer R; Brocato RM; Maroney M; Hooper F
AJR Am J Roentgenol; 1997 Sep; 169(3):667-71. PubMed ID: 9275874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
